Dynamics of tumor in situ fluid circulating tumor DNA in recurrent glioblastomas forecasts treatment efficacy of immune checkpoint blockade coupled with low-dose bevacizumab von Wang, Dayang, Zhang, Jiubing, Bu, Chaojie, Liu, Guanzheng, Guo, Guangzhong, Zhang, Ziyue, Lv, Guangming, Sheng, Zhiyuan, Yan, Zhaoyue, Gao, Yvshuai, Wang, Meiyun, Liu, Gang, Zhao, Ruijiao, Li, Tianxiao, Ma, Chunxiao, Bu, Xingyao

Volltext